SVB Leerink upgraded shares of Spruce Biosciences ( NASDAQ:SPRB – Free Report ) from a market perform rating to an outperform rating in a research note released on Friday, Marketbeat Ratings reports. They currently have $9.00 price target on the stock, up from their previous price target of $3.00. Other equities analysts have also issued research reports about the company. JMP Securities lifted their price objective on Spruce Biosciences from $7.00 to $8.00 and gave the company an outperform rating in a research note on Wednesday, August 16th.

https://www.dailypolitical.com/2023/09/09/spruce-biosciences-nasdaqsprb-upgraded-to-outperform-at-svb-leerink.html

#dailypolitical